The Pax3 and Pax7 paralogs cooperate in neural and neural crest patterning using distinct molecular mechanisms, in Xenopus laevis embryos  by Maczkowiak, Frédérique et al.
Developmental Biology 340 (2010) 381–396
Contents lists available at ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logyThe Pax3 and Pax7 paralogs cooperate in neural and neural crest patterning using
distinct molecular mechanisms, in Xenopus laevis embryos
Frédérique Maczkowiak a,b,c, Stéphanie Matéos a,b, Estee Wang d, Daniel Roche a,b,c,
Richard Harland d, Anne H. Monsoro-Burq a,b,c,⁎
a Institut Curie, Centre de Recherche, Centre Universitaire, F-91405 Orsay, France
b CNRS UMR 3347, INSERM U1021, Orsay, France
c Université Paris Sud-11, Orsay, France
d UC Berkeley, MCB Department, USA⁎ Corresponding author. CNRS UMR 3347, INSERM
Universitaire, Batiment 110, F-91405 Orsay cedex, Fran
E-mail address: anne-helene.monsoro-burq@curie.u
0012-1606/$ – see front matter © 2010 Elsevier Inc. A
doi:10.1016/j.ydbio.2010.01.022a b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 16 September 2009
Revised 6 January 2010
Accepted 20 January 2010
Available online 29 January 2010
Keywords:
Pax3
Pax7
Brain
Neural crest
Mesoderm
FGF
WNT
Otx2
Krox20
Snail2
PatterningPax3 and Pax7 paralogous genes have functionally diverged in vertebrate evolution, creating opportunity for
a new distribution of roles between the two genes and the evolution of novel functions. Here we focus on the
regulation and function of Pax7 in the brain and neural crest of amphibian embryos, which display a different
pax7 expression pattern, compared to the other vertebrates already described. Pax7 expression is restricted
to the midbrain, hindbrain and anterior spinal cord, and Pax7 activity is important for maintaining the fates
of these regions, by restricting otx2 expression anteriorly. In contrast, pax3 displays broader expression
along the entire neuraxis and Pax3 function is important for posterior brain patterning without acting on
otx2 expression. Moreover, while both genes are essential for neural crest patterning, we show that they
do so using two distinct mechanisms: Pax3 acts within the ectoderm which will be induced into neural crest,
while Pax7 is essential for the inducing activity of the paraxial mesoderm towards the prospective neural
crest.U1021, Institut Curie, Centre
ce.
-psud.fr (A.H. Monsoro-Burq).
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Pax3 and Pax7 are members of the Pax family of transcriptional
regulators. They contain two DNA binding domains, a paired domain
and a paired-type homeodomain (Chalepakis et al., 1994a,b; Gruss and
Walther, 1992; Jostes et al., 1990). Human syndromes with Pax3
mutations (Waardenburg syndrome types I and III) andmousemutants
(Splotch/Pax3 mutant and Pax7 mutant) have highlighted their
prominent roles in early embryogenesis and during adulthood
(Chalepakis et al., 1994a; Epstein et al., 1991; Read and Newton, 1997;
Tassabehji et al., 1992). In adults, they are essential in muscle
homeostasis and repair (Buckingham, 2006; Kuang and Rudnicki,
2008; Le Grand and Rudnicki, 2007). In embryos, they are major
regulators of central nervous system, neural crest and paraxial
mesoderm patterning and differentiation. During vertebrate evolution,
Pax3 and Pax7 duplicated from an ancestral gene (Holland et al., 1999;
McCauley and Bronner-Fraser, 2002; Osorio et al., 2005). Furtherduplications have occurred in zebraﬁsh, which has four genes: Pax3/
Pax3b and Pax7/Pax7b (Thompson et al., 2008). While such gene
duplicationsmay retain functional overlapbetweenPax3 andPax7, they
also open the possibility for distribution of the various functions
assumed by the ancestral gene and the evolution of novel functions for
each paralog. Indeed, the comparison of Pax3 and Pax7 gene expression
shows differences between vertebrates (see below). The analysis of the
functional implications of such differences reveals distinct functions
between Pax3 and Pax7 in various cell types, such as muscle or neuron
progenitors (Relaix et al., 2004; Thompson et al., 2008).
Here we focus on the early mechanisms of neural and neural crest
development. During mouse, chick and ﬁsh neurulation and organ-
ogenesis, Pax3 and Pax7 are both expressed in overlapping patterns in
the central nervous system, including expression in the mesenceph-
alon, the hindbrain and the spinal cord, with some subtle regional
differences between the two genes (Borycki et al., 1999; Goulding
et al., 1994a; Mansouri et al., 1996; Minchin and Hughes, 2008;
Thompson et al., 2008). In their various locations along the anterior–
posterior axis, Pax3 and Pax7 domains of expression are restricted to
the dorsal part of the central nervous system. Ventral midline-derived
signals, such as sonic hedgehog and noggin, restrict their expression
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such as BMP4, promote their dorsal expression at early steps of neural
patterning (Goulding et al., 1994a; Liem et al., 1997; McMahon et al.,
1998; Monsoro-Burq et al., 1995; Monsoro-Burq et al., 1996). In turn,
Pax3 is an essential regulator of neural tube dorsal–ventral patterning.
Splotch mutants are strongly affected in dorsal neural tube develop-
ment and present severe spina biﬁda (Borycki et al., 1999; Epstein
et al., 1991). Reciprocally, Pax3 gain of function in mouse embryos
alters ventral neural tube patterning (Tremblay et al., 1996).
Strikingly, the Pax7 homozygous mutants do not show any abnormal
phenotype in the central nervous system, suggesting a signiﬁcant
functional overlap between Pax3 and Pax7 activities within the neural
tube of mouse embryos (Mansouri et al., 1996). Indeed, Pax7 knock-in
into the Pax3 locus in Splotch mutants rescues the spina biﬁda
phenotype (Relaix et al., 2004). At later stages of brain morphogen-
esis, in chick embryos, Pax3 and Pax7 expression is regulated at the
isthmus by Fgf8 and En2/Pax2–5; in turn, Pax3 and Pax7 are involved
in tectum organisation downstream of Fgf8/En2/Pax2–5 (Matsunaga
et al., 2001). During later mouse mesencephalon development, Pax3
and Pax7 expression partially segregate and control the development
of speciﬁc neuronal populations (Thompson et al., 2008).
Pax3 and Pax7 are also major regulators of neural crest early
development. The neural crest is a transient vertebrate-speciﬁc pop-
ulation of pluripotent and migratory progenitors, from which are
derived peripheral neurons and glia, melanocytes and other pigment
cells, as well as craniofacial structures (Le Douarin and Kalcheim,
1999). The neural crest delaminates from the dorsalmost part of the
neural tube, after being induced in the lateral neural plate (also
named the neural border, (Meulemans and Bronner-Fraser, 2004)
during gastrulation and early neurulation. Mutations in the human
Pax3 gene, which can be heterozygous or rarely homozygous, affect a
subset of neural crest derivatives, such as the melanocytes, which, in
particular, contribute to ear development and to pigmentation of skin
and hair (Waardenburg syndrome I and III), but initial neural crest
development seems to occur normally since other neural crest
structures are formed (Read and Newton, 1997). In the mouse, ho-
mozygous Pax3 mutants display reduced to absent neural crest
derivatives, especially in posterior areas, while heterozygous mice
only show reduced belly pigmentation (Auerbach, 1954; Franz and
Kothary, 1993; Relaix et al., 2004). Strikingly, the craniofacial
structures form rather normally in Pax3 homozygotes, suggesting
that the initiation of neural crest development is not affected in the
cephalic neural crest (Relaix et al., 2004). Mouse Pax7 mutants show
only late cephalic neural crest defects (Mansouri et al., 1996),
suggesting that Pax3 activity is sufﬁcient for early neural crest.
Overlap between Pax3 and Pax7 functions in the neural tube and
neural crest is further evidenced by the rescue of the Pax3 mutant
phenotype by knock-in of Pax7 into the Pax3 locus, showing that
increasing Pax7 activity compensates for Pax3 loss (Relaix et al.,
2004). Because of the overlapping expression and roles, and because
the double mutant Pax3/Pax7 has not yet been described, the
contributions of Pax3 or Pax7 to mammalian cranial neural crest
induction remain unknown. However, in non-mammalian species,
both Pax3 and Pax7 have been implicated in neural crest induction. In
particular, Pax3 appears as the earliest neural border-speciﬁc marker
in the Xenopus laevis gastrula (Monsoro-Burq et al., 2005), a similar
pattern being assumed by Pax7 in chick embryos (Basch et al., 2006).
In either species, Pax3 (Xenopus) or Pax7 (chick) cooperate with other
regulators and induce the early neural crest marker Snail2 (Basch
et al., 2006; Monsoro-Burq et al., 2005). By contrast, the respective
roles of Xenopus Pax7 and chick Pax3 in neural crest induction remain
to be explored. Moreover, besides interactions between the neural
plate and the ectoderm, interactions between the paraxial mesoderm
and the ectoderm are essential in neural crest induction (Bonstein
et al., 1998; Monsoro-Burq et al., 2003). Although Pax3 and Pax7 are
important regulators of paraxial mesoderm development (Boryckiet al., 1999; Goulding et al., 1994b; Relaix et al., 2004, 2005), their
potential participation in the neural crest inducing activity of the
paraxial mesoderm remains to be explored.
During later neural crest development, Pax3 and Pax7 are found in
migrating neural crest cells (NCC) with species-speciﬁc differences:
cranial NCC in mouse, cranial and trunk NCC in chick and zebraﬁsh
embryos (Lacosta et al., 2005; Mansouri et al., 1996; Minchin and
Hughes, 2008). When NCC condense into dorsal root ganglia in chick
embryos, Pax3 remains expressed while Pax7 expression is extin-
guished (Lacosta et al., 2005). Later, both Pax3 and Pax7 are detected
in the neural crest derived pigment cells, melanocytes or xantho-
phores in chick or zebraﬁsh (Lacosta et al., 2005; Minchin and Hughes,
2008). However, only Pax3was detected in mammalian melanoblasts
(Lacosta et al., 2005). In conclusion, the survey of Pax3 and Pax7
expression proﬁles in various vertebrates outlines the variability of
common and gene-speciﬁc patterns, especially in the neural crest
lineage.
In this study, we have examined and compared the respective roles
of Pax3 and Pax7 in neural and neural crest patterning in Xenopus
embryos. We show striking differences in the expression domains of
these two genes compared to other vertebrate species, notably in the
neural tube and neural crest, that could indicate different functional
specialization between the two genes in amphibians. Using a series of
gain-of-function and loss of function experiments, we address the
regulation of Pax7 expression by FGF, Wnt, retinoids and Pax3 during
early neural patterning. We then analyze and compare Pax3 and Pax7
speciﬁc function in early anterior–posterior brain patterning. Fi-
nally, we explore their respective roles in neural crest induction by the
paraxial mesoderm.
Materials and methods
Embryo and explant manipulation
X. laevis embryos were obtained by in vitro fertilization using
standard procedures and were staged according to Nieuwkoop and
Faber developmental table (Nieuwkoop and Faber, 1994; Sive et al.,
2000). Embryos were injected in one blastomere at the two to four-
cell stage unless otherwise noted. Co-injection of mRNA encoding
nuclear-targeted lacZ traced the progeny of the injected blastomere.
Staining for beta-galactosidase activity was done prior to ﬁnal ﬁxation
(Monsoro-Burq, 2007). The recombination of stage 9 ectoderm from
the animal cap to stage 10.25 prospective paraxial mesoderm (dorsal–
lateral marginal zone, DLMZ), as an assay for neural crest induction,
was described in Bonstein et al. (1998) and Monsoro-Burq et al.
(2003).
Semi-quantitative RT-PCR
Embryoswere lysed in proteinase K-containing lysis buffer, followed
by DNase treatment and reverse transcription (Sive et al., 2000), the
minus-RT sample is a control sample ampliﬁed without the reverse
transcription step, monitoring potential DNA contamination. EF1a was
used to calibrate the reaction (21 cycles, Krieg et al., 1989).Muscle actin,
snail2, vent1, myod, pax3 and pax7 primers (Mizuseki et al., 1998;
Monsoro-Burq et al., 2005; Rupp and Weintraub, 1991; Shapira et al.,
1999; Stutz and Spohr, 1986, and this study) were used in 25-cycle
ampliﬁcation 32P-dCTP-traced PCR (see Supplemental Fig. 2A for
sequences).
Whole mount in situ hybridization (ISH) and immunostaining
Embryos were ﬁxed and prepared for whole mount in situ
hybridization (ISH) according to a shortened protocol optimized for
superﬁcial structures (Monsoro-Burq, 2007). Antisense digoxigenin-
labelled RNA probes were used at a ﬁnal concentration of 1 µg/ml.
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(Monsoro-Burq et al., 2005), myoD (Hopwood et al., 1989), otx2
(Lamb et al., 1993), en2 (Hemmati-Brivanlou et al., 1991), krox20
(Bradley et al., 1993), gbx2 (PCR-ampliﬁed and cloned into pGEM-T
Easy (Promega) using sequence in Tour et al. (2002a)), dct (Kumasaka
et al., 2003) and hoxb9 (Sharpe et al., 1987). For immunostaining of
myotome after ISH, the bleached embryos were saturated in 10%
serum then incubated in 12/101 monoclonal antibody (Kintner and
Brockes, 1984) before washes and peroxidase (HRP-DAB) staining.
The embryos were examined after vibratome (30 µm) sectioning.
Messenger RNA synthesis, antisense morpholinos
Messenger RNAs used for microinjection were obtained by in vitro
transcription of plasmids containing the desired cDNA using the
mMessage mMachine SP6 or T7 kits (Ambion) and puriﬁed on G50
sephadex spin columns. The following plasmids were used: nlacZ
(125–250 pg/cell), fgf8a (CS107-fgf8a;10–50 pg/cell) (Monsoro-Burq
et al., 2003), wnt7b (50 pg/cell) (Chang and Hemmati-Brivanlou,
1998; Grammer et al., 2000), dnRARα (250 pg/cell) (Blumberg et al.,
1997), X. laevis pax3 (AY725269; cloned into CS107-Pax3, 125 pg/
cell) (Monsoro-Burq et al., 2005), mouse pax3 (CS107-mpax3, 125 pg/
cell) (Goulding et al., 1991; Monsoro-Burq et al., 2005), mouse pax3-
EnR (subcloned into pCS107 by R. Harland and B. Martin, 62–125 pg/
cell; Ridgeway and Skerjanc, 2001), X. laevis pax7 (full-length cDNA
subcloned into pCS107, 250–500 pg/cell, this study, Genbank
AY725267), X. laevis pax7-myc (pax7 ORF fused to N-terminal myc
tags and subcloned into pCS107, 62–125 pg/cell, this study), X. laevis
pax7-EnR (pCDNA3-pax7-EnR, pax7 DNA binding domain fused to
Engrailed repressor domain, 62 pg/cell (Chen et al., 2006). Silencing of
selected genes was performed using translation blocking antisense
morpholino oligonucleotides (GeneTools, see Supplemental Fig. 2B for
sequences): Fgf8MO (Monsoro-Burq et al., 2003), beta-cateninMO
(Genetools), Pax3MO (Monsoro-Burq et al., 2005), Pax7MO (transla-
tion blocking), Pax7 mismatch MO and Pax7 splice MO (this study).
The speciﬁcity of Pax3MO and Pax7MO (translation blocking MOs)
MOs was tested by 35S-labelled in vitro transcription-and-translation
reaction using TNT kit (Promega). Relative morpholino concentration
was maintained constant compared to the volume of the injected cell:
whole embryo injections were done in all blastomeres at the two or
four-cell stage with a total dose four times higher than injections done
into one blastomere of four-cell stage embryos.
Results
pax3 and pax7 display both partially overlapping and distinct expression
domains in mesoderm, neural plate and brain of X. laevis embryos
We previously subcloned and sequenced the full-length pax7
cDNA from NIBB EST library (http://xenopus.nibb.ac.jp, Genbank
accession #AY725267). As expected, the encoded protein shows high
similarity with other vertebrate Pax7 especially within the paired and
octapeptide-homeodomain parts of the protein (Supplemental
Figs. 1A–B) and synteny in Xenopus tropicalis (not shown). In contrast,
Pax3 and Pax7 proteins, although very closely related, can be clearly
distinguished by several amino acid sequence features and are quite
distinct at the nucleotide level (Supplemental Figs. 1C and 2C),
allowing construction of a non-ambiguous phylogenetic tree.We have
analyzed the available Pax3/7 sequences in chordates, using neigh-
bour-joining method (Clustal W in MacVector and MEGA4 software
(Tamura et al., 2007). This tree groups the cyclostomes (lamprey and
hagﬁsh) genes in the Pax7 group, while both amphioxus and ascidian
are foundwith a single Pax3/7 gene. This conﬁrms that the duplication
of the Pax3/7 ancestor has occurred at the base of the vertebrate
lineage (Fig. 1A; O'Neill et al., 2007). Moreover, we have also compiledthe available data on Pax7 gene organisation using both X. laevis BAC
sequencing and X. tropicalis genome data (Supplemental Fig. 2).
We compared the onset of pax3, muscle actin, and pax7 tran-
scription in vivo using semi-quantitative RT-PCR on whole embryos
(Fig. 1B). As we described before, pax3 appears the earliest, at gastrula
stage 11 (Monsoro-Burq et al., 2005), followed by muscle actin which
is detected by stage 12.5. Pax7 appears last, being faintly detected at
mid-neurula stage 14, then being reinforced in tadpoles (from stage
26 onwards). We have further compared expression patterns of pax3,
pax7, snail2 and myoD by whole mount ISH, at neurula stages. In
agreement with the RT-PCR data, we found that pax7 is faintly
expressed by stage 14 in the anterior neural plate (Fig. 1C, a, c) and
reinforced in the brain and trunk paraxial mesoderm by stage 18
(Fig. 1C, b, d). This expression is thus detected at a later develop-
mental stage than pax3 (detected at the neural border at stage 14 and
in neural plate and paraxial mesoderm later on, Fig. 1C, e, f), snail2
(detected in the neural crest at both stages 14 and 18, Fig. 1C, g, h) and
myoD (expressed in the entire paraxial mesoderm at stages 14 and 18,
Fig. 1C, i, j).
At tailbud stage, pax3 and pax7 remain expressed in overlapping
but distinct domains in both neural tissue and somites. At stage 23, a
strong pax7 staining is observed in the posterior part of the brain and
in the paraxial mesoderm (Figs. 2A–B, D–E). This pattern differs from
pax3 expression, which extends the entire length of the nervous
system (Figs. 2C, F). In addition, pax3 stains the hatching gland in the
ectoderm (Fig. 2C). Double stainingwith krox20 helps deﬁne the pax7-
positive brain level: pax7 is expressed in a domain centered on
rhombomeres 3 and 5 (Figs. 2G–H, J–K, yellow arrows), including
mesencephalon and anterior spinal cord while pax3 labels the entire
length of the neural tube (Figs. 2I, L). Transverse trunk sections (line in
Fig. 2J), double-stained with 12–101 muscle marker show that pax7
labels the superﬁcial part of the myotome as well as a dorsal spinal
cord domain excluding the roof plate, while pax3 labels the hypaxial
myotome and the entire dorsal domain of the spinal cord (Figs. 2M–O).
Since the origins of the dermatome are unclear at this stage, we cannot
rule out a contribution of gene expression to this domain. Neither of
the two genes is expressed in the migrating neural crest (compare to
krox20-positive neural crest from rhombomere 5 in Figs. 2K–L).
Both pax7 and pax3 respond to FGF, WNT and retinoic acid pathways
patterning activity
The differences observed in the expression of pax7 and pax3might
result from the cues that deﬁne the anterior–posterior neural pattern
in the neurula embryos. During neural development, FGF signaling
contributes to neural induction and anterior–posterior polarization of
the neural tube (Delaune et al., 2005; Fletcher et al., 2006). Moreover,
FGF8 is a major brain patterning signal at the midbrain–hindbrain
boundary (Koebernick et al., 2006). FGF8 expression is ﬁrst detected
at this boundary by stage 16 in X. laevis neurulae, which is similar to
the observed onset time of pax7 expression in the brain (Fig. 1C).
We analyzed the role of FGF signaling on pax7 patterning by gain
and loss of function experiments. Fgf8amRNA injections were done in
one dorso-animal blastomere at the 4-cell stage, at a low dose (5 pg)
that only marginally affects gene expression on the contralateral side
as monitored by snail2 expression (n=8, 75% of unilateral expansion
of snail2 at stage 18, 12% expansion in the anterior neural fold, not
shown, (Monsoro-Burq et al., 2003). Increased FGF8 signaling resulted
in expanded pax7 expression: at neurula stage 18, the anteriormost
expression domain, located in the prospective forebrain was lost
while the emerging rhombencephalon domain and the mesoderm
domain were shifted anteriorly (black arrows) (Fig. 3A). At tailbud
stage (stages 20–25), pax7was found expressed in the whole brain on
the injected side, extending anteriorly towards the forebrain (n=31,
84% expansion, Fig. 3C, arrow). Interestingly, the posterior boundary
of pax7 expression in the rhombencephalon remained unchanged. In
Fig. 1. Expression of pax7 and pax3 compared during neurulation in Xenopus laevis. (A) A bootstrap phylogenetic tree illustrates the clear grouping of pax7 and pax3 paralogs in
vertebrates while the chordate have a single Pax3/7 gene. Accession numbers are given in Supplemental Fig. 1. (B) RT-PCR analysis on whole embryos shows the early onset of pax3
expression during gastrulation (i.e. at times of neural crest induction), whereas pax7 is detected at mid-neurulation, after muscle actin (MA) is detected. EF1α is used as a baseline
control. (C) In situ hybridization on stage-matched sibling embryos conﬁrms the late onset of pax7, in brain ﬁrst (c) then in paraxial mesoderm, and the lack of expression in the
neural crest progenitor area (c, d). In contrast, pax3 and snail2 label neural crest (e–h). Myod marks paraxial mesoderm (i, j).
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domain in the dorsal neural tube (n=27, 100% expansion, not shown,
(Monsoro-Burq et al., 2005)) as well as krox20 expression in
rhombomeres 3 and 5 (n=24, 83% expanded, not shown). Converse-
ly, knocking down both FGF8a and FGF8b forms by a translation
blocking morpholino against X. laevis FGF8 (FGF8MO, (Fletcher et al.,
2006; Monsoro-Burq et al., 2005), Supplemental Fig. 2B) efﬁciently
downregulated both pax7 and pax3 expression in the brain on the
injected side (Pax7: n=20, 85% decrease to complete loss of
expression, Figs. 3B, D; Pax3: n=10, 60% decrease, not shown). This
was similar to the decrease observed after injection of a dominant-
negative FGF receptor (XFD, not shown). This result shows that FGF
signaling, and FGF8 in particular, play an essential part in initiating
and patterning pax7 expression in the brain.
We have then asked at what time of neural patterning were FGF
signals required to establish a proper pax7 pattern in the brain: either
as part of the general neural anterior–posterior patterning or more
speciﬁcally during isthmus formation.We blocked FGF signaling using
the FGF receptor inhibitor SU5402 during three periods of develop-
ment, in three groups of sibling embryos: group 1 was treated from
late blastula to early tadpole stage (from stages 8 to 22), group 2
during neural induction only (from stages 8 to 12) and group 3 during
neural patterning (from stages 12 to 22) (Delaune et al., 2005). Theﬁrst two treatments inhibit neural induction and mesoderm forma-
tion as noted by the reduced sox2 expression (100% reduction, n=21;
DMSO treated sibling are 92% normal, n=24) and the severe gas-
trulation defects observed in these embryos. The third treatment
avoids perturbing general mesoderm and neural induction as shown
by sox2 expression analysis: 96% of the embryos show normal sox2
staining (n=23) while 100% of DMSO treated siblings are normal
(n=22). However, this treatment alters posteriorization of the neural
plate as marked by decreased hoxb9 expression (Supplemental Fig. 3,
n=23, 61% decreased expression; DMSO treated siblings are 100%
normal (n=22); Fletcher and Harland, 2008; Roche et al., 2009). In all
cases, pax7 expression was analyzed at stage 22. For all three periods
of treatment, we observed pax7 expression in the brain in the
majority of the embryos. There was an altered pax7 pattern in the
anteriormost part of the nervous system that still forms when
embryos are treated early (treatments done between stages 8–12
(group 1) and 8–22 (group 2): n=24, 71% of embryos showed
slightly reduced to normal staining, 29% had a loss of staining,
compared to DMSO treated siblings (n=23, 100% normal staining)
(data not shown). This reduction correlated with the abnormal sox2
expression. There was no signiﬁcant loss of pax7 expression in group-
3 embryos: normal expressionwas observed in themajority of both in
DMSO treated embryos, (n=23, 100% normal) and SU-treated
Fig. 2. Distinct pax7 and pax3 patterns in central nervous system and paraxial mesoderm at tailbud stages. (A–C) Front views of stage 22 embryos (A) show pax7 expression in the
caudal part of the brain (B), whereas pax3 labels both the whole brain and the hatching gland (C). (D–F) Side views (D) illustrate pax7 restriction to mesencephalon, hindbrain
and anterior spinal cord whereas pax3 is found along the entire anterior–posterior length of the central nervous system. Pax7 labels the central paraxial mesoderm while pax3 is
found in hypaxial cells. (G–L) Dorsal (G–I) and side (J–L) views of tailbud stage 24, with double staining for pax3 or pax7 and krox20, which labels hindbrain rhombomeres r3 and r5
(yellow arrows), conﬁrms the limited extent of pax7 expression along the spinal cord. (M–O) Tailbud stage 24 transverse sections were double-stained with 12–101 myotome
marker (brown). This shows pax7 expression in the alar plate of the anterior-most spinal cord and medial myotome (N) and pax3 in the roof plate, alar plates and in the hypaxial
myotome (O).
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decrease in the extent of Pax7 domain and staining intensity (see
Supplemental Fig. 3). This result indicates that FGF signaling plays a
major role in regulating pax7 expression during early brain patterning
but only marginally modulates pax7 pattern at later neurulation
stages such as during isthmus formation.
Additionally, FGFs cooperate with Wnt and Retinoic acid signals to
pattern the midbrain and hindbrain (Blumberg et al., 1997; McGrew
et al., 1997). We have either over-expressed Wnt7b or injected a beta-
catenin morpholino to activate or block theWnt-beta-catenin pathway
respectively. As observed for FGF signals, an increased Wnt signaling
resulted in an enlarged pax7 expression domain (n=20, 65% increase,
Fig. 3E), with a posterior border shift, similar to what is observed for
pax3 in sibling embryos (n=13, 77% increased; not shown, (Mon-
soro-Burq et al., 2005)). Conversely, pax7 expression was strongly
decreased to absent in beta-catenin morpholino-injected embryos
(n=35, 77% decrease, Fig. 3F). Retinoic acid signaling was blocked
using a dominant-negative form of retinoic acid receptor alpha
(dnRARα, Blumberg et al., 1997), resulting in decreasedpax7 expression
in the injected area (n=13, 70% decrease, Fig. 3G). Together, these
results show that the three main posterior neural patterning pathways,
namely FGF,Wnt andRA, are active indeﬁning thepax7-positive domain;
that they act during early neurulation rather than mid–hindbrain
boundary formation, and that the differences observed between pax3
and pax7 domains in X. laevis are not due to a loss of competence to
respond to these patterning cues in pax7 gene regulatory elements.
Pax3 regulates pax7 expression in the brain
Focusing on neural patterning, we next asked if Pax3, which is
expressed earlier and in a larger domain that pax7 in neural tissue,
was involved in pax7 patterning. In order to analyze the regulation of
pax7 expression by Pax3, we used an antisense morpholino-mediated
depletion of Pax3 in conjunction with a rescue experiment (Monsoro-
Burq et al., 2005). Using an in vitro reticulocyte lysate transcription-
coupled-to-translation assay, we have ﬁrst veriﬁed that Pax3MO
efﬁciently and speciﬁcally blocked the translation of X. laevis Pax3
cDNA (Fig. 4A, lanes 1–3), while it affected neither the translation of
mouse Pax3 cDNA (Fig. 4A, lane 4), nor that of the Pax7 cDNA (see
Supplemental Fig. 2C and below Fig. 6A, lane 5).
In vivo, pax7 expression is strongly decreased by Pax3 knock-
down (20–30 ng) in the brain, analyzed at stages 22–25, while thecontralateral side remains unaffected (81%, n=106) (Fig. 4C). This
inhibitory effect is rescued when a moderate amount of mouse pax3
mRNA (100 pg), insensitive to the Pax3MO, used is co-injected with
Pax3MO (30 ng): in experimental series where Pax3MO-injected
embryos showed a 90% loss of pax7 (n=25) and expression in only
10% of the embryos, the sibling group, co-injected with Pax3MO and
mouse pax3 mRNA, displayed restored pax7 expression in 46% of the
embryos while 54% still showed decreased pax7 expression (n=39)
(Fig. 4B). We then analyzed the phenotype of Pax3-depleted embryos
on transverse sections to evaluate the extent of loss of pax7 expression
in the dorsal–ventral neural axis. Compared to the normal situation
(Fig. 4F) and to the contralateral side (Fig. 4G), the size of the dorsal
brain domain is reduced and pax7 expression strongly impaired
(Fig. 4G). A very similar phenotype was obtained by injecting a
repressor form of Pax3 (Pax3-engrailed repressor domain fusion;
Ridgeway and Skerjanc, 2001): pax7 expression was decreased both
in wholemount views and on transverse sections, accompanied by a
reduced size of the alar plate on the injected side (n=21, 95%
decrease, Figs. 4D, H). The loss of pax7 expression seems independent
from a potential mechanical or indirect effect due to the spina biﬁda
phenotype caused by Pax3MO or Pax3EnR since some embryos with
severe spina biﬁda still displayed Pax7 staining on the non-injected
side, while the expression was lost in the injected cells (not shown).
We next examined the effect of increasing Pax3 activity in vivo by
injection of Xenopus or mouse mRNA around the prospective neural
plate (250 pg into one dorsal animal blastomere at 4-cell stage). A
clear expansion of pax7 expression is observed in about half of the
injected embryos (54% expansion, n=94 Fig. 4E), which is rather
modest when compared to sibling embryos analyzed for Snail2 ex-
pression as a positive control (69% expansion, n=54, not shown). A
similar effect was obtained using mouse Pax3 mRNA (expansion in
8 embryos out of 13, not shown). On transverse sections, it appeared
that the expansion is due to an enlargement of the alar plates,
accompanied by the expansion of pax7 expression dorsally (Fig. 4I).
The sum of these observations suggest that Pax3 regulates general alar
plate patterning, acts as an activator in pax7 regulation and is required
for pax7 induction and patterning in the brain.
Pax7 is expressed later, in brain, myotome, lymph heart and melanocytes
In tadpole stage embryos, pax7 is expressed in four main locations:
the brain, the superﬁcial part of the somite, the lymph heart and the
Fig. 3. pax7 pattern in the brain is positively regulated by FGF, Wnt and retinoid signals. (A–D) FGF8 gain of function expands pax7 expression into forebrain, while FGF8 depletion
leads to lack of pax7 at induction stage (stage18, A, B) and in later development (stage 22, C, D). (E–F)Wnt7b over-expression and beta-catenin morpholino injections demonstrate
the requirement for Wnt signals in pax7 patterning. (G) Similarly, blocking retinoic acid signaling resulted in defective pax7 expression.
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to midbrain, hindbrain and the most anterior part of the spinal cord,
contrasting to pax3 expression that extends along the entire neuraxis
(Fig. 5A/A,E, red arrows). In the paraxial mesoderm, both pax7 and
pax3 are found with patterns similar to those of stage 22 embryos
(Figs. 2 and 5A/A,E, compare to myoD staining in I). At later stages
(stage 32 onwards), a similar pax7 brain expression is observed, as
well as a faint more posterior spinal cord staining (Fig. 5A/B,F). While
pax3marks the trigeminal ganglia (Fig. 5A/F, arrow), pax7 expression
is not observed at this location but is found in the lymph heart (Ny
et al., 2005), (Fig. 5A/B, arrow). At this stage, pax7 expression is no
longer detected in the paraxial mesoderm (Fig. 5A/B) while pax3 still
strongly labels the hypaxial muscle and intersomitic areas (Fig. 5A/F,
compare to myoD in Fig. 5A/J) (Martin and Harland, 2001). We have
further documented pax7 expression in the lymph heart by comparing
it to lymph heart marker prox1 expression in stage-matched sibling
embryos: we found that pax7 is expressed earlier than prox1, but both
genes are expressed later (Fig. 5B/A–D). At swimming tadpole stage
41, pax7 is found in a dispersed population of cells in the body wall,
while pax3 is found at the edge of the migrating paraxial muscle
progenitors (Fig. 5A/C, G, yellow arrows, compare tomyoD staining in
Fig. 5A/K). Pax7 is detected again in the myotome, in cells that align at
the edge of each myotome (Fig. 5D). We propose that these cells may
constitute the future satellite cell population described in mature
muscles (Chen et al., 2006). At stage 45, pax7 and pax3 are both
expressed in themelanocytes (Fig. 5A/D, H).Wehave analyzed the co-
localisation of pax7 expression with eumelanin by comparing pictures
of the same embryos, taken either before bleaching or after in situ
staining (Fig. 5C). While neither myoD nor prox1 — (used here
as bleaching and in situ hybridization control) stain these cells
(Fig. 5A/L), there is a striking co-localisation of pax7 staining and
melanosomes (Fig. 5C/A,B, arrows).
Pax7 loss of function affects brain, muscle and melanocyte development
We have designed a Pax7-speciﬁc translation blocking antisense
morpholino oligonucleotide that has no complementarity to Pax3
cDNA sequence (Supplemental Fig. 2F). We have checked using in
vitro transcription–translation reticulocyte lysate assay, that Pax7MO
efﬁciently blocks Pax7 translation (Fig. 6A, lanes 1–3), but not
translation from a construct lacking the MO complementary sequence
(Pax7-myc-GFP fusion, Fig. 6A, lane 4) nor from a Pax3 construct
(Fig. 4A, lane 5). Pax3MOdid not block Pax7 translation either (Fig. 6A,lane 5). Embryoswere injected bilaterallywith either control, Pax7MO
or Pax3MO. Until early-mid-neurula stages (stage 14), embryos
injected with either Pax7MO (70 ng) or Pax3MO (70–80 ng) did not
exhibit obvious morphological defects compared to sibling embryos
(data not shown). This indicates that gastrulation and neurulation
initiate normally, consistent with the lack of Pax7 expression at these
stages. At late neurula and tadpole stages, threemain phenotypeswere
observed after Pax7MO bilateral injection in vivo: head atrophy,
shortened axis with (posterior) spina biﬁda and melanocyte loss.
These phenotypes were compared to that of control and Pax3MO-
injected siblings, which also display spina biﬁda and loss of
melanocytes, but less severe head malformation (Fig. 6). The majority
of the Pax7MO-injected tadpoles did not close the neural tube and
exhibited a shortened axis with mild (brain is closed, 10.3%, n=398,
Fig. 6D, f) to severe spina biﬁda (87.4%, n=398) (Fig. 6D, k). When
embryos that exhibit severe spina biﬁda developed further, they died
between stages 24 and 26 (i.e. too early for melanocyte lineage
analysis). The embryos with less severe neural defects survived until
stages 33–40, provided that the vitelline envelope was manually
removed (Fig. 6D, g–j and l–o, n=38): these latter embryos showed
severely altered anterior morphology, with reduced head, reduced
eyes and few/nomelanocytes (severemelanocyte loss, with no lateral
migration, 81%, n=38). A similar phenotype was observed when a
Pax7-EnR fusion was injected bilaterally (not shown).
At stage 23, Pax3 morphants were fairly normal, although cell
death dorsal to the neural tube was observed (not shown), suggesting
that unspeciﬁed neural crest cells die at the end of neurulation
(Monsoro-Burq et al., 2005). These embryos did not hatch autono-
mously and were devitellinized manually around tailbud stages 22–
23. At stages 26–33, Pax3MO-injections resulted in a shorter body axis
than normal but more elongated than Pax7 morphants (Fig. 6D, q, v).
In addition, head and ﬁn defects were prominent, spina biﬁda was
frequently observed especially in the posterior neural tube (18%,
n=162) (Fig. 6D, p–r and u–w). Those features mimic the Splotch
mutant phenotype (Auerbach, 1954; Epstein et al., 1991).
We have used embryos displaying the milder phenotype to assess
muscle and pigment formation at tadpole stage by ISH. Stage 26–33
Pax7morphants showedmyoD staining only in a reduced posterior area
(Fig. 6D, j, o), while Pax3MO injections resulted in a rather normally
elongated myoD area along the side of the embryo (Fig. 6D, t, y),
although the segmentation patternwas severely altered (Supplemental
Fig. 4).Melanocyte differentiationwas assessed in stage 26–40 embryos
using either dct staining for melanocyte precursors (Fig. 6D) or
Fig. 4. Pax3 regulates pax7 expression and alar plate patterning in the brain. (A) Pax3 depletion using an antisense morpholino (Pax3MO) speciﬁcally prevents Xenopus laevis pax3
translation in vitro (lane 3). Pax7MO and a control MO have no effect on Xenopus laevis pax3 translation while Mus musculus pax3 is unaffected by Pax3MO. (B) Following Pax3
depletion in vivo (bar 1), pax7 expression is severely reduced,Mus musculus Pax3mRNA efﬁciently rescues the decrease in pax7 expression (bar 2). (C) Unilateral depletion of Pax3
results in loss in pax7 expression; (D) a similar effect is observed after Pax3-EnR over-expression. (E) Gain in Pax3 activity increases and expands pax7 expression. (F–I) Transverse
sections show that the loss in pax7 (C, D, G, H) is accompanied by reduced alar plates development, while Pax3 increase results in expanded pax7-expressing alar plates (I).
Bar=500 µm.
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fertilized with sperm from a pigmented male (not shown). Pax7
morphants lacked dct expression (81.6%, n=38, Fig. 6D, h, m and i, n,
compare to stage-matched control in Fig. 6D, c, d). Similarly, the number
of melanocytes in Pax3MO-injected embryos was either reduced (i.e.
somemelanocytes are observed dorsal to the neural tube, but very few
melanocytes have migrated laterally, 30%, n=103 Fig. 6H) to severely
depleted (no melanocyte observed, Fig. 6O, 40%, n=103, compared to
stage-matched control in Fig. 6D, c, d). Together, these observations
suggest that head and brain development, muscle and neural crest
derivative formation are affected by the depletion of Pax7 and Pax3
activity in vivo. However, the phenotypes observed present clear gene-
speciﬁc features.
To address the speciﬁcity of this phenotype, we have rescued the
Pax7MO phenotype by co-injecting the Pax7-myc fusion, insensitive
to the MO. Embryos injected with Pax7MO exhibit the defects
described above on the injected side at the end of neurulation
(stage 18, 54% of defective embryos, n=111), but the sibling embryos
co-injected with Pax7MO and Pax7-myc mRNA are fairly normal in
74% of cases, n=291) (Fig. 6E). The rescued embryos also displayed
rescued expression of myoD and dct (Fig. 6F). To further address the
speciﬁcity of the observed phenotype, we have injected a morpholino
with 5-mismatches compared to Pax7MO (see Supplemental Fig. 2C).
In this case, both morphology of the embryos and gene expressionwere normal (Supplemental Fig. 5). Furthermore, we have designed a
splice-blocking morpholino, preventing splicing of the ﬁrst intron
(Supplemental Fig. 2). In this case, we evaluated the level of pax7
knock-down to 60% by semi-quantitative RT-PCR at stage 22, using
embryos injected with the Pax7 splice MO in all four blastomeres
(Supplemental Fig. 6A). Whole embryo injections resulted in a similar
phenotype as described above for Pax7MO (although is a slightly
lower proportion of the embryos with most severe phenotypes) and
snail2,myod and dct expressionwere affected similarly (Supplemental
Fig. 6).
Pax7 function is essential for neural crest formation
Since morphological alterations appear during neurulation, we
examined if Pax7, like Pax3, is important in neural and neural crest
development inXenopus.Wehaveanalyzed theeffects of Pax7depletion
on krox20 expression, (krox20 labels hindbrain rhombomeres 3 and 5,
and neural crest emigrating from rhombomere 5, Fig. 7A) and on snail2
expression (Fig. 7F) in stage 18 neurulae. Krox20 expression was
severely altered both in the brain and in the neural crest: rhombomere
3/5 staining was either shifted posteriorly or lost, while rhombomere 5
neural crest was diminished or lost (95%, n=61; Figs. 7B, C). Similarly,
snail2 expression was strongly reduced or completely abolished on the
injected side (74%, n=43; Figs. 7G, H). Similar phenotypes were
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n=76 for snail2; Figs. 7D, I) and Pax3MO (75%, n=45 for krox20 and
76% n=47 for snail2; Figs. 7E, J), suggesting redundant effects of Pax3
and Pax7 in this process.To assess the speciﬁcity of Pax7 morpholino phenotype, we have
performed a rescue experiment, using a pax7-GFP-myc fusion. Sibling
embryos were injected unilaterally with either Pax7MO, or co-
injected by Pax7MO and the pax7-GFP-myc mRNA (125 pg). Snail2
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expression (95% strong decrease, n=20, Fig. 7L). In contrast, co-
injections resulted in restored snail2 expression (50% normal, 50%
mild decrease, n=18, Fig. 7M).
Thus,we showhere that Pax7 function is essential for full neural crest
formation.However, aswe did not observepax7 expression at theneural
border or in the neural crest progenitors themselves, we have proposed
two hypotheses in order to explain how Pax7 may control neural crest
formation:Pax7maybe important for central nervous systempatterning
along the anterior–posterior axis, and thus secondarily inﬂuence neural
crest formation at the edge of the posterior domain; alternatively, Pax7
may be important for paraxial mesoderm development and thus
secondarily in its inductive function in neural crest early development.
We have explored these two hypotheses below.
Pax7 controls brain patterning by maintaining midbrain and hindbrain
fates
In order to analyze brain patterning, we have looked at four regional
markers: otx2 which labels the forebrain and midbrain (Fig. 8A);
gbx2 and engrailed2 (en2) which mark the mid–hindbrain boundary
(Figs. 8F, K); and krox20 for the hindbrain (Fig. 7). At early neurula stage
(stages 12–13), otx2 and gbx2 expression were normal after Pax7
unilateral depletion (not shown), suggesting that the initial onset of
neural anterior–posterior patterning occurs normally (Tour et al.,
2002a), and in agreement with the late onset of pax7 expression
(Fig. 1). At mid-late neurula stages, unilateral Pax7MO injections
resulted in otx2 expansion in more posterior areas (69.2%, n=65;
Figs. 8B–D), while gbx2, en2 and krox20 were either shifted posteriorly
or lost (respectively 89.3%, n=28 for gbx2, 69%, n=52 for en2 and 95%,
n=61 for krox20; Figs. 7B, C and 8G–I, L–N). Pax7EnR mRNA injections
resulted in a similar phenotype: otx2 expansion in 84.6% of the embryos
(n=104; Fig. 8D) and diminished en2 (69%, n=52; Fig. 8N) and krox20
(70%, n=57; Fig. 7D). In this case, gbx2 expression was only slightly
shifted posteriorly (Fig. 8I). In contrast to Pax7 depletion phenotype,
Pax3MOdid not perturb otx2 pattern (symmetrical expression in 72% of
the injected embryos, n=50). However, Pax3 depletion had similar
posterior shifting or loss on gbx2 (75%, n=28; Fig. 8J), en2 (73%,
n=11; Fig. 8O) and krox20 (75%, n=45; Fig. 7E). In conclusion, these
experiments uncover a novel role for Pax7 in maintaining the mid–
hindbrain boundary (prospective isthmus) and hindbrain fates and
preventing the posterior expansion of forebrain and midbrain fates
during early brain patterning (at stage of neural closure). In relationship
to neural crest patterning, this altered midbrain and hindbrain
patterning could secondarily result into defective neural crest induction.
Pax7 is needed for neural crest induction by the paraxial mesoderm
Morphological andmyoD analysis of Pax7morphants suggests that
Pax7 loss has profound effects on paraxial mesoderm development
(Fig. 6). Paraxial mesoderm signaling activity is essential during
neural crest induction (Bonstein et al., 1998; Monsoro-Burq et al.,
2003). Defective paraxial mesoderm, after Pax7 depletion, could
impair neural crest induction in the overlying ectoderm, and thus
suggest how Pax7 depletion may affect neural crest induction. To
address this issue, we have used heterochronic recombinants,
using ectoderm from the blastocoel roof from a stage 9 blastula
embryo, recombined with the dorsal–lateral marginal zone (prospec-Fig. 5. Pax7 expression in tadpoles. A/ At tailbud stage (st. 25–32) pax7 exhibits a dynamic
expression remains restricted to hindbrain and anterior spinal cord (A–B). Pax7 is also found
the spinal cord, in the hypaxial muscle and trigeminal ganglia (E–F, arrows) or to myod ex
expressed in scattered cells on the side of the embryo (yellow arrows) and cells that align at
pax7 and pax3, but notmyod, label melanocytes (D, H, L). B/ During lymph heart developme
both pax7 and prox1 expression overlap in the lymph heart (B, B′, D, D′ and transverse section
arrow; Ny et al., 2005). C/ Late tadpoles where photographed before bleaching to position th
pax7 (yellow arrows). D/ Some pax7-positive cells aligned at the edge of each myotome in stive paraxial mesoderm) of a stage 10.25 early gastrula. This assay
results in potent snail2 and other neural crest marker induction in the
ectoderm, as well as melanocyte differentiation later on (Bonstein
et al., 1998; Monsoro-Burq et al., 2003) (Figs. 9A, D; G, lane5).
Ectoderm (Figs. 9B; G, lane 3) or paraxial mesoderm (Figs. 9C; G,
lane 4) explants grown in isolation, do not express snail2. When the
ectoderm was dissected from Pax3MO injected embryos, snail2
induction was strongly impaired (Fig. 9G, lane 6) while Pax7MO in
the ectoderm did not prevent snail2 induction (Fig. 9G, lane 7). In
sharp contrast, depletion of Pax3 in the paraxial mesoderm did not
alter snail2 induction, despite defective muscle actin speciﬁcation
(Figs. 9F, G, lane 8). Moreover, Pax7 function in the paraxial meso-
derm explant is essential for snail2 induction in the ectoderm, as well
as for proper muscle actin expression (Figs. 9E; G, lane 9; F).
The results above suggested that Pax3 and Pax7 act in different
tissues during neural crest induction. This does not rule out that the
two proteins could have similar functions. To address if they display
redundant functions, we have attempted to rescue Pax3 and Pax7
knock-down by Pax7 and Pax3 gain of function respectively. In both
situations, while the homologous gain of function (Pax3 for Pax3MO
and Pax7 for Pax7MO) restored snail2 expression, neither Pax3 nor
Pax7 were able to compensate for the knock-down of Pax7 or Pax3
respectively (Fig. 10). This was also true when a later stage was
considered: Pax7 did not rescue the loss of melanocytes observed in
the Pax3 morphants. All these data suggest that Pax3 and Pax7 exert
distinct functions, in distinct tissues in early and later neural crest
development in Xenopus.
Finally, as we observed thatmyod expression was defective in Pax7
morphants (Fig. 6), we asked if the effect of Pax7 in the paraxial
mesodermwas due to altered mesoderm patterning. We examined the
paraxial mesoderm markers myoD and muscle actin and the ventral
mesoderm marker vent1 in the recombinants (Fig. 9G). We found that
both in Pax3 and Pax7-depleted dorsal–lateral marginal zone meso-
derm, paraxial patterning is defective and that ventral marker vent1 is
higher than in controls at neurula stage. However, we did not ﬁnd a
molecular difference between Pax3 and Pax7morphantmesoderm that
could account for their distinct neural crest inducing ability.
In conclusion, these results show a dramatic difference in the
mode of activity of Pax7 and Pax3 in neural crest induction, Pax7
being essential for the inductive signaling from the paraxial
mesoderm, while Pax3 is needed in the ectoderm.
Discussion
In this work, we address pax7 pattern regulation in the brain of X.
laevis embryos, and Pax7 function in neural and neural crest early
development. We provide a parallel analysis of Pax3 and Pax7 func-
tion, using a speciﬁc antisense morpholino strategy, which uncovers
both common and distinct functions for these two paralogous genes.
In particular, both genes are important for neural crest induction, but
they act by two strikingly different mechanisms.
Pax7 is expressed in a spatially restricted pattern in X. laevis central
nervous system, and is activated by posteriorizing signals and Pax3
Pax3 and Pax7 have diverged early in vertebrate evolution; their
sequences can be clearly grouped on a phylogenetic tree, and speciﬁc
primers, probes andmorpholinos can be designed (Fig. 1, Supplementalexpression in the myotome, which vanishes at late stage, while brain and spinal cord
in the lymph heart (B, arrow). This contrasts to pax3 expression in the entire length of
pression in the epaxial muscles (I–J). At swimming tadpole stage (st 41–45), pax7 is
the edge of the myotome cells (see D/), while pax3 andmyodmark muscle (G, K). Both
nt, pax7 is detected earlier than the lymph heart marker prox1 (A, A′, C, C′). By stage 33,
s b, d, yellow arrows), while prox1 is also expressed adjacent to the cardinal vein (green
e melanocytes (B) and then pax7was revealed (A). Most melanocytes were labelled by
tage 41 tadpoles and may constitute the prospective satellite cell population (arrows).
390 F. Maczkowiak et al. / Developmental Biology 340 (2010) 381–396Figs. 1 and 2). Their respective expression in the alar plates of the central
nervous system, in the migrating neural crest and in the paraxial
mesoderm varies according to the different species described, suggest-
ing that the respective functionswithin the Pax3/7 subfamily could varyin different species. We provide here the ﬁrst precise comparison of
Pax3 and Pax7 expression in X. laevis.
In X. laevis, pax7 and pax3 display clearly distinct expression
patterns and pax7 pattern differs in several respects from pax7
Fig. 7. Pax7 and Pax3 are essential for hindbrain and neural crest patterning. The early phenotype of Pax7 morphants was analyzed at stage 18. Control siblings show normal
expression of krox20 (A) and snail2 (F). Pax7 morphants exhibit either a severe loss of krox20 (B) and snail2 (G), or a posterior shift of rhombomeres r3 and r5 (C, arrows)
accompanied by reduced snail2 expression (H). A similar phenotype is observed in Pax7EnR injected embryos (D, I) or Pax3 morphants (E, J). Pax7MO phenotype is rescued by
injection of Pax7-myc mRNA), insensitive to the morpholino (Fig. 6): snail2 expression is restored (L shows two morphants and (M) two siblings injected with MO and the rescue
construct).
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pax3 is detected, either by RT-PCR using speciﬁc primers, or by in
situ hybridization (Fig. 1). Pax3 is present in the prospective hatching
gland, the lateral aspect (alar plates) of the neural plate comprising
the prospective neural crest domain. In contrast, the pax7 expression
appears in the paraxial mesoderm and in the midbrain and hindbrain
at later neurulation stages, which differs from observations of Pax7
expression in the chick gastrula stages (Basch et al., 2006). Pax7 is
neither detected in the prospective neural crest domain nor in theFig. 6. Pax7 morphants are affected in earlier stages than Pax3 morphants, although both dis
(lane 3) but neither that of a pax7-gfp fusion lacking the MO-binding sequence (lane 4), nor o
gastrulation (yellow), while a few of them exhibit milder phenotypes allowing us to follow t
end of neurulation except for posterior spina biﬁda in the more severely affected ones (yello
phenotype for Pax7 morphants, and in Pax3 morphants. Severe loss refers to the lack of dct
associated to lack of melanocyte migration. (D) Sibling control embryos (a–e), Pax7morphan
(u–y) phenotype were analyzed at the end of neurulation (stage 23), tailbud stage 33 or
prominent head, brain, mesoderm andmelanocytes defects. (E)The Pax7MO phenotype is re
details. (F) Both myoD and dct expression are rescued by pax7 mRNA injection into Pax7 mmigrating neural crest. This later onset of pax7, after neural tube
closure, is also observed in lamprey, zebraﬁsh, chick and mouse
neurulae (Mansouri et al., 1996;Matsunaga et al., 2001;McCauley and
Bronner-Fraser, 2002; Minchin and Hughes, 2008). However, pax7
expression in a small subpopulation of migrating cranial neural crest
cells is seen in zebraﬁsh, chick and mouse embryos (Mansouri et al.,
1996; Matsunaga et al., 2001; Minchin and Hughes, 2008).
These two initial expression patterns in the CNS resolve into two
distinct domains, pax3 being detected along the entire anterior–play mesoderm and neural crest defects. (A) Pax7MO blocks in vitro translation of pax7
f pax3 (5). (B) Pax7 morphants display early and severe elongation defects shortly after
heir development further (red). In contrast, Pax3 morphants are rather normal until the
w). (C) Melanocyte development was analyzed in later stage embryos, among the mild
positive or pigmented cells, while “mild loss” refers to decreased melanocyte number
ts with mild (f–j) or severe (k–o) phenotype, Pax3morphants with mild (p–t) or severe
swimming tadpole stage 45, and stained for dct and myod at stage 33. They display
scued by co-injections with Pax7-myc mRNA, insensitive to the morpholino. See text for
orphants (see text for details).
Fig. 8. Pax7 and Pax3 regulate mid–hindbrain boundary maintenance. Pax7 depletion leads to forebrain–midbrain expansion as seen by otx2 posterior expansion (B, C). This is
accompanied by loss or posterior shift of the mid–hindbrain boundary (Gbx2, G, H) and En2 (L, M). A similar phenotype is observed after PaxEnR (D, I, N). Pax3 morphants do not
exhibit expanded otx2 domain (E, yellow arrow indicates similar posterior boundaries on each side), but they also display defective or shifted mid–hindbrain boundary (J, O). Red
arrows indicate the extent of shift between the posterior boundary on control non-injected (left) side, and the shifted boundary on injected (right) side.
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hindbrain and anteriormost spinal cord, but not in rest of the spinal
cord (Fig. 2). This strikingly differs from expression of both Pax3 and
Pax7 all along the neuraxis in chick and mouse, but is similar to the
described pattern in shark, zebraﬁsh, and salmon (Borycki et al., 1999;
Freitas et al., 2006; Goulding et al., 1993a; Minchin and Hughes, 2008;
O'Neill et al., 2007; Sibthorpe et al., 2006). Additional differences
include that pax7 does not label the trigeminal ganglia as pax3 does
(Baker et al., 2002) and pax7 – but not pax3 – is expressed in the
lymph heart (Ny et al., 2005) (Fig. 5). Both pax3 and pax7 are
expressed in melanocytes in Xenopus (Fig. 5) whereas they differen-
tially label both melanophores and xanthophores in zebraﬁsh
(Minchin and Hughes, 2008).
In contrast, the expression of pax3 and pax7 in the paraxial
mesoderm, respectively in the hypaxial and the superﬁcial myotome
(Figs. 2 and 5), is in agreement with expression in other vertebrates
(Borycki et al., 1999; Goulding et al., 1993b). In mouse embryos,
distinct enhancers control the distinct regions of pax7 expression in
brain and neural crest derivatives (Lang et al., 2003). Our expression
pattern analysis in Xenopus suggests that evolution has acted
differentially on these enhancers.
We have explored the possibility that the differences in pax7
expression compared to other species, in particular in the spinal cord,
could be due to different response to the posteriorizing signals that
pattern the neural plate, namely FGF, Wnt and retinoid signaling. We
have found that pax7 expression is modulated by these three pathways,
similarly to other genes expressed in the posterior neural cells, such as
pax3, hoxb9 or snail2 (Fig. 3 and data not shown). The restricted pattern
observed for pax7 could nonetheless depend on lower sensitivity to
endogenous signaling levels rather thanqualitatively different response.Additionally, we did not observe a signiﬁcant role of FGF signaling at the
time of isthmus formation (Supplemental Fig. 3), suggesting that
general early anterior–posterior patterning broadly controls pax7
among other neural restricted markers.
In Splotch mutant mice, pax7 expression in the somites and spinal
cord is upregulated (Borycki et al., 1999). Here we show that Pax3,
which expression domain comprises that of pax7, positively controls
pax7 expression in the brain, in parallel to general development of
the alar plates (Fig. 4). We did not observe broad ectopic expression in
the spinal cord after Pax3 misexpression (Fig. 4), suggesting that
regulation by Pax3 is active only in the brain and anterior spinal cord,
i.e. around pax7 normal domain, compared to the mouse situation.
Although not expressed in neural crest progenitors, Pax7 is essential for
brain, neural crest and myotome patterning
Pax3 and Pax7 play an essential role in neural crest induction in
Xenopus and chick embryos respectively (Basch et al., 2006; Mon-
soro-Burq et al., 2005; Sato et al., 2005). Moreover, Pax7 and Pax3 are
thought to display redundant activities in themouse neural crest, since
the replacement of pax7 in the pax3 locus sufﬁces to rescue the neural/
neural crest phenotype, while the paraxial mesoderm phenotype
remains severe (Relaix et al., 2004). Here, we have explored the
possibility that Pax7 displays a similar function to Pax3 in Xenopus
neurulae. Surprisingly, pax7was not detected in the neural fold at the
time of neural crest induction (late gastrula, early neurula) when pax3
is abundantly expressed (Fig. 1). At later stages, neither pax3 nor pax7
transcripts are detected in the migrating neural crest (Fig. 2). This
expression contrasts with the pattern in chick and mouse embryos
(Basch et al., 2006;Mansouri et al., 1996). Later on, however, both pax3
Fig. 9. Pax7 is essential for the neural crest inducing activity of the paraxial mesoderm, while Pax3 acts in the ectoderm. (A)We have recombined the stage 9 blastocoel roof ectoderm
to stage 10.25 prospective paraxial mesoderm (dorsal–lateral marginal zone), a classical assay for neural crest induction in the ectoderm. Ectoderm and DLMZ were dissected from
either control uninjected or Pax3 or Pax7 morphants (see color code). Ectoderm (B) or DLMZ (C) grown alone until stage 18 do not express snail2, while the recombined explants
(D) do. When the DLMZ comes from Pax7 morphant (E), snail2 induction is strongly impeded, while Pax3 depleted DLMZ do not perturb snail2 induction (F). RT-PCR analysis
(G) further shows that ectoderm alone (lane 3) does not express snail2, myoD or muscle actin (MA), DLMZ alone expresses only myoD and MA (lane 4) while the recombinant
expresses both (lane 5). Snail2 induction is impaired if the ectoderm is depleted for Pax3 (lane 6) but not for Pax7 (lane 7). In contrast, snail2 induction is normal if DLMZ comes from
Pax3 morphants (lane 8) but is impaired for Pax7 depleted DLMZ (lane 9). In both Pax3- and Pax7-depleted DLMZ,myoD andMA expression are decreased while vent1 is abnormally
upregulated.
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several other species (Lacosta et al., 2005;Minchin andHughes, 2008).
However, rather surprisingly, although we did not ﬁnd pax7
expression in the neural crest progenitors, our knock-down experi-
ments show that Pax7 depletion dramatically affects embryo elon-
gation, brain, and neural crest development. Dct andmyoD expression
analysis conﬁrmed that myotome and pigment formation were
severely affected, the Pax7 phenotypes being even more dramatic
than that of Pax3 depletion, and rescued by adding back Pax7
transcripts (Fig. 6). Additionally, neural crest and brain induction and
early patterning are strongly affected (Figs. 7 and 8). This is in contrast
to the Pax7 mouse mutants, or with zebraﬁsh morphants, which only
display a mild and late phenotype (Mansouri et al., 1996; Minchin and
Hughes, 2008). In mouse, pax3 and pax7 patterns overlap largely and
Pax3 and Pax7 exert redundant functions; in zebraﬁsh, pax7 has a late
onset after initial neural and mesoderm patterning. We have testedpossible functional redundancy between Pax3 and Pax7 in Xenopus,
by attempting to rescue Pax3 and Pax7 knock-downs by Pax7 and
Pax3 respectively (Fig. 10): Pax3 did not rescue snail2 expression in
Pax7 morphants, nor did Pax7 rescue snail2 expression or melanocyte
differentiation in Pax3 morphants. Our results, compared to those in
the other species, strongly suggest a re-distribution of functions
between Pax3 and Pax7 in vertebrates. Such gene function re-
shufﬂing as has also been described for Snail family members (Sefton
et al., 1998).
Pax7 participates in neural crest induction via its role in brain and
paraxial mesoderm patterning
We have analyzed Pax3 and Pax7 respective roles in early brain
patterning, at times of isthmus formation. We show that both
genes are essential activators to allow the maintenance of the mid–
Fig. 10. Pax3 and Pax7 do not display redundant functions in neural crest induction and development. Pax3 morphant phenotype (A) is rescued by gain of function for Pax3 (B) but
not Pax7 (C). At a later stage, Pax7 does not restore melanocyte development in Pax3 morphants either (G). Conversely, Pax3 is not sufﬁcient to rescue Pax7 depletion (D, F), in
contrast to Pax7 gain of function (E). These data indicate that the two proteins do not display similar roles in neural crest induction and development. Injected side is on the right
(yellow arrow).
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and that Pax7 speciﬁcally prevents ectopic posterior expansion of
otx2. Otx2 speciﬁes forebrain–midbrain fates (Rhinn et al., 1999; Tour
et al., 2002b). Otx2 and gbx2 domains are initially set up shortly after
the start of neurulation and the two factors exert reciprocal negative
regulation that deﬁnes the border between their respective domains,
this border being the mid–hindbrain boundary (Acampora et al.,
2001; Tour et al., 2002a; Ye et al., 2001). The onset of otx2 and gbx2
domains is initiated normally in presence of Pax7MO (stages 12–14),
but the maintenance of this boundary is perturbed (en2) as well as
hindbrain patterning (krox20) and cranial neural crest formation
(krox20, snail2) (Figs. 7 and 8). Pax3 depletion has a similar outcome
on hindbrain formation, although Pax3 does not seem to restrict otx2
expression (Fig. 8), in agreement with pax3 expression pattern in the
forebrain (Figs. 1 and 2). Our results from depletion analysis correlate
with the phenotypes obtained by gain of function in chicken embryos:
Pax3/7 electroporation promotes ectopic anterior hindbrain and optic
tectum development in the diencephalon (Matsunaga et al., 2001).
Hence we show here that Pax3 and Pax7 cooperate to promote early
hindbrain development, a major source of cranial neural crest
progenitors (Creuzet et al., 2005).
In addition to interactions within the ectoderm–neurectoderm
layer, neural crest induction requires signals from paraxial mesoderm
(Bonstein et al., 1998; Monsoro-Burq et al., 2003). We observe here
severe defects inmesoderm formation and axis elongation in the Pax7
morphants, suggesting that the neural crest inducing function of
paraxial mesoderm might be altered as well (Fig. 6). By using an
explant recombination strategy, we show that Pax3 and Pax7 par-
ticipate in neural crest induction by two distinct mechanisms: Pax3activity is essential in the ectoderm, conﬁrming previous work on
Pax3 role in Xenopus neural crest induction (Monsoro-Burq et al.,
2005; Sato et al., 2005); while Pax7 acts in the paraxial mesoderm,
which in turn promotes induction in the ectoderm (Fig. 9). Given the
relatively late onset of Pax7 expression, compared to neural crest
induction, our data also suggest that Pax7-mediated paraxial
mesoderm induction participates in maintaining or amplifying the
initial Pax3-mediated neural crest induction in the ectoderm. Thus,
the two genes cooperate in neural crest induction, but by two distinct
strategies (Figs. 9 and 10). In addition, the roles of Pax3 and Pax7 in
the ectoderm have been exchanged between species, when Xenopus
and chick are compared (Basch et al., 2006). Our observations also
show that Pax3 and Pax7 do not play redundant roles in the paraxial
mesoderm (Fig. 6 and Supplemental Fig. 3), similar to the mouse
situation (Relaix et al., 2004), but here, their relative importance in
the mesoderm seems to be swapped since the Pax7 depletion has
earlier and more profound effects than Pax3 loss, which is opposite to
the mouse mutant (Mansouri et al., 1996; Relaix et al., 2004).
In conclusion, our study analyzes how the functions of two closely
related Pax3 and Pax7 paralogs have been distributed in the amphibian
X. laevis, during neural and neural crest induction. We use their
strikingly distinct expression patterns, in the brain, the spinal cord and
in the paraxial mesoderm of Xenopus embryos to experimentally
explore their speciﬁc function in each of these tissues, in the absence
of redundant activity of the other paralog. We show that Pax3 and Pax7
cooperate in mid–hindbrain boundary formation, by promoting
hindbrain fates, and that Pax7 speciﬁcally restricts otx2 expression.
Additionally, Pax3 and Pax7 cooperate to trigger neural crest induction,
by acting in the ectoderm and in the mesoderm respectively.
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